TR200103587T2 - Mono-ve çift ikame edilmiş 3-propil gama aminobutirik asitler. - Google Patents
Mono-ve çift ikame edilmiş 3-propil gama aminobutirik asitler.Info
- Publication number
- TR200103587T2 TR200103587T2 TR2001/03587T TR200103587T TR200103587T2 TR 200103587 T2 TR200103587 T2 TR 200103587T2 TR 2001/03587 T TR2001/03587 T TR 2001/03587T TR 200103587 T TR200103587 T TR 200103587T TR 200103587 T2 TR200103587 T2 TR 200103587T2
- Authority
- TR
- Turkey
- Prior art keywords
- disorders
- mono
- substituted
- double
- gamma aminobutyric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/20—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/32—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut bulus formül (I)'in bir dizi yeni mono-ve çift ikame edilmis 3-propil gama aminobutirik asitleridir. Bilesikler epilepsinin, bayginlik nöbetlerinin, hipokinezinin, kafatasi bozukluklarinin, nörodejeneratif bozukluklarin, depresyonun, anksiyetenin, panigin, agrinin, nöropatalojik bozukluklarin, arteritin, uyku bozukluklarinin, IBS ve gastrik hasarin tedavisinde terapötik ajanlar olarak fayda saglar. Bilesikler hazirlanma metodlari ve faydali ara ürünler de ayrica bulusun bir parçasidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13848599P | 1999-06-10 | 1999-06-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200103587T2 true TR200103587T2 (tr) | 2002-04-22 |
Family
ID=22482232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/03587T TR200103587T2 (tr) | 1999-06-10 | 2000-05-31 | Mono-ve çift ikame edilmiş 3-propil gama aminobutirik asitler. |
Country Status (43)
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7164034B2 (en) | 1999-06-10 | 2007-01-16 | Pfizer Inc. | Alpha2delta ligands for fibromyalgia and other disorders |
US6620829B2 (en) | 2000-10-17 | 2003-09-16 | Warner-Lambert Company | Method of treating noninflammatory cartilage damage |
AU2002310409C1 (en) * | 2001-06-11 | 2008-04-17 | Xenoport, Inc. | Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
ITMI20011308A1 (it) | 2001-06-21 | 2002-12-21 | Nicox Sa | Farmaci per il dolore cronico |
WO2003063845A1 (en) | 2002-01-31 | 2003-08-07 | Warner-Lambert Company Llc | Alpha 2 delta ligands to treat tinnitus |
NI200300043A (es) * | 2002-03-28 | 2003-11-05 | Warner Lambert Co | AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA. |
US20030225149A1 (en) | 2002-04-30 | 2003-12-04 | Blazecka Peter G. | Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids |
US7071339B2 (en) | 2002-08-29 | 2006-07-04 | Warner Lambert Company Llc | Process for preparing functionalized γ-butyrolactones from mucohalic acid |
CN101862317A (zh) | 2002-12-13 | 2010-10-20 | 沃尼尔·朗伯有限责任公司 | 用于治疗纤维肌痛和其它疾病的普加巴林衍生物 |
WO2004054565A1 (en) * | 2002-12-13 | 2004-07-01 | Warner-Lambert Company Llc | Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
CA2679030A1 (en) | 2002-12-13 | 2004-07-01 | Warner-Lambert Company Llc | Alpha-2-delta ligand to treat lower urinary track symptoms |
CA2451267A1 (en) | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
ITMI20022658A1 (it) | 2002-12-17 | 2004-06-18 | Nicox Sa | Farmaci per il dolore cronico. |
WO2005002585A1 (en) * | 2003-07-02 | 2005-01-13 | Warner-Lambert Company Llc | Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor |
EP1663398B1 (en) | 2003-09-12 | 2009-11-25 | Pfizer Limited | Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline reuptake inhibitors |
BRPI0414781A (pt) * | 2003-09-25 | 2006-11-21 | Warner Lambert Co | aminoácidos com afinidade para a proteìna (alfa)2(delta) |
BRPI0414819A (pt) | 2003-09-25 | 2006-11-14 | Warner Lambert Co | pró-fármacos de aminoácidos com afinidade para a proteìna alfa2delta |
WO2006043171A2 (en) * | 2004-10-23 | 2006-04-27 | Warner-Lambert Company Llc | Methods of using alpha2delta-1 selective compounds |
US8957226B2 (en) * | 2005-09-15 | 2015-02-17 | Ucb Pharma S.A. | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
US20070141684A1 (en) | 2005-12-21 | 2007-06-21 | Pfizer Inc | Preparation of gamma-amino acids having affinity for the alpha-2-delta protein |
AR061728A1 (es) * | 2006-06-30 | 2008-09-17 | Pfizer Prod Inc | Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1 |
US20080153888A1 (en) | 2006-12-22 | 2008-06-26 | Recordati Ireland Limited | Alpha-2-delta ligand/nsaid therapeutic treatment of lower urinary tract disorders |
WO2009136375A1 (en) * | 2008-05-08 | 2009-11-12 | Pfizer Inc | Treatment of interstitial cystitis |
EP2509596B1 (en) | 2009-12-08 | 2019-08-28 | Case Western Reserve University | Gamma aminoacids for treating ocular disorders |
CN101914031B (zh) * | 2010-07-30 | 2013-08-28 | 中国广州分析测试中心 | 普瑞巴林衍生物及其应用 |
LT3364958T (lt) * | 2015-10-23 | 2023-06-12 | Navitor Pharmaceuticals, Inc. | Sestrin-gator2 sąveikos moduliatoriai ir jų panaudojimas |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
AU9137091A (en) * | 1990-11-27 | 1992-06-25 | Northwestern University | Gaba and l-glutamic acid analogs for antiseizure treatment |
KR950701625A (ko) * | 1992-05-20 | 1995-04-28 | 인드라니 무크하르지 | 항발작 치료용 gaba 및 l-글루탐산 동족체(gbab and l-glutamic acid analogs for antiseizure treatment) |
US5637767A (en) * | 1995-06-07 | 1997-06-10 | Warner-Lambert Company | Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid |
SI0934061T1 (en) * | 1996-07-24 | 2003-10-31 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
CA2263663C (en) * | 1996-10-23 | 2006-05-30 | Justin Stephen Bryans | Substituted gamma aminobutyric acids as pharmaceutical agents |
PT1032555E (pt) * | 1997-10-27 | 2006-07-31 | Warner Lambert Co | Aminoacidos ciclicos e derivados uteis como agentes farmaceuticos |
-
2000
- 2000-05-31 AT AT00938022T patent/ATE419231T1/de not_active IP Right Cessation
- 2000-05-31 CZ CZ20080760A patent/CZ301608B6/cs not_active IP Right Cessation
- 2000-05-31 GE GE4667A patent/GEP20074142B/en unknown
- 2000-05-31 CN CNB00808730XA patent/CN1196671C/zh not_active Expired - Fee Related
- 2000-05-31 AU AU53119/00A patent/AU776723C/en not_active Ceased
- 2000-05-31 WO PCT/US2000/015070 patent/WO2000076958A2/en active Application Filing
- 2000-05-31 DK DK00938022T patent/DK1192125T3/da active
- 2000-05-31 RS YUP-870/01A patent/RS50352B/sr unknown
- 2000-05-31 IL IL14696900A patent/IL146969A0/xx active IP Right Grant
- 2000-05-31 TR TR2001/03587T patent/TR200103587T2/tr unknown
- 2000-05-31 EA EA200101134A patent/EA004398B1/ru not_active IP Right Cessation
- 2000-05-31 CN CNB2005100037011A patent/CN1310872C/zh not_active Expired - Fee Related
- 2000-05-31 CA CA2689997A patent/CA2689997A1/en not_active Abandoned
- 2000-05-31 NZ NZ515668A patent/NZ515668A/xx not_active IP Right Cessation
- 2000-05-31 AP APAP/P/2002/002388A patent/AP1397A/en active
- 2000-05-31 SK SK5045-2009A patent/SK287399B6/sk not_active IP Right Cessation
- 2000-05-31 EE EEP200100672A patent/EE200100672A/xx unknown
- 2000-05-31 ME MEP-448/08A patent/MEP44808A/xx unknown
- 2000-05-31 MX MXPA01012319A patent/MXPA01012319A/es active IP Right Grant
- 2000-05-31 OA OA1200100326A patent/OA11962A/en unknown
- 2000-05-31 UA UA2001128283A patent/UA72519C2/uk unknown
- 2000-05-31 SK SK1764-2001A patent/SK287247B6/sk not_active IP Right Cessation
- 2000-05-31 ES ES00938022T patent/ES2317839T3/es not_active Expired - Lifetime
- 2000-05-31 HU HU0201601A patent/HUP0201601A3/hu unknown
- 2000-05-31 DE DE60041256T patent/DE60041256D1/de not_active Expired - Lifetime
- 2000-05-31 PT PT00938022T patent/PT1192125E/pt unknown
- 2000-05-31 CA CA2374755A patent/CA2374755C/en not_active Expired - Fee Related
- 2000-05-31 CZ CZ20014285A patent/CZ300834B6/cs not_active IP Right Cessation
- 2000-05-31 BR BR0011727-7A patent/BR0011727A/pt not_active IP Right Cessation
- 2000-05-31 JP JP2001503818A patent/JP3904452B2/ja not_active Expired - Fee Related
- 2000-05-31 EP EP00938022A patent/EP1192125B9/en not_active Expired - Lifetime
- 2000-05-31 SI SI200031015T patent/SI1192125T1/sl unknown
- 2000-05-31 DZ DZ003253A patent/DZ3253A1/fr active
- 2000-05-31 RS RSP-2009/0257A patent/RS20090257A/sr unknown
- 2000-05-31 KR KR1020017015841A patent/KR100694735B1/ko not_active IP Right Cessation
- 2000-06-07 AR ARP000102808A patent/AR033335A1/es active IP Right Grant
- 2000-06-09 PE PE2000000577A patent/PE20010285A1/es not_active Application Discontinuation
- 2000-06-09 CO CO00043067A patent/CO5200791A1/es not_active Application Discontinuation
-
2001
- 2001-11-26 ZA ZA200109711A patent/ZA200109711B/en unknown
- 2001-11-28 IS IS6181A patent/IS6181A/is unknown
- 2001-12-05 NO NO20015949A patent/NO327746B1/no not_active IP Right Cessation
- 2001-12-06 CU CU20010291A patent/CU23101A3/es not_active IP Right Cessation
- 2001-12-06 IL IL146969A patent/IL146969A/en not_active IP Right Cessation
- 2001-12-07 CR CR6529A patent/CR6529A/es not_active Application Discontinuation
-
2002
- 2002-01-02 MA MA26462A patent/MA26804A1/fr unknown
- 2002-01-09 BG BG106292A patent/BG65561B1/bg unknown
- 2002-01-10 HR HR20020025A patent/HRP20020025A2/hr not_active Application Discontinuation
- 2002-10-30 HK HK02107862.8A patent/HK1046401B/zh not_active IP Right Cessation
-
2005
- 2005-09-29 HK HK05108612A patent/HK1076626A1/xx not_active IP Right Cessation
-
2009
- 2009-02-26 CY CY20091100228T patent/CY1108827T1/el unknown
- 2009-03-13 NO NO20091094A patent/NO20091094L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200103587T2 (tr) | Mono-ve çift ikame edilmiş 3-propil gama aminobutirik asitler. | |
DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
ATE280154T1 (de) | Verzweigte alkylpyrrolidin-3-carbonsäuren | |
MX9806069A (es) | Novedosos amino acidos ciclicos substituidos como agentes farmaceuticos. | |
HUP0105027A2 (hu) | N-Heterociklusos vegyületek karbonsavszármazékai és karbonsav-izoszterei és alkalmazásuk | |
PT888325E (pt) | Novos amino acidos ciclicos como agentes farmaceuiticos | |
ATE410506T1 (de) | Behandlung der pompeschen krankheit | |
ES2169848T3 (es) | Nuevos aminoacidos ciclicos coronados como agentes farmaceuticos. | |
BR0108977A (pt) | Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina | |
DE69737719D1 (de) | Substituierte gamma-aminobuttersäurederivate als arzneimittel | |
ATE343388T1 (de) | Pde-v hemmer zur behandlung von morbus parkinson | |
ES2185591T3 (es) | Amino hererociclos utiles como agentes farmaceuticos. | |
ATE446285T1 (de) | Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3- thiosubstituierte indol-2-alkinsäuren | |
BR0011728A (pt) | Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide | |
RU94046141A (ru) | Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция | |
ATE131055T1 (de) | Behandlung von kognitiven störungen. | |
DE689838T1 (de) | Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen | |
DE60132436D1 (de) | Retinolsäure-rezeptor beta-2 und gentherapievektoren für die behandlung von neurologischen erkrankungen | |
ECSP003522A (es) | Acidos 3- propilgamma- aminobutiricos mono- y, disustituidos | |
CA2245647A1 (en) | Novel bridged cyclic amino acids as pharmaceutical agents |